Autopsy report · NCT02483897

Effect of Tetracaine on Pain Management and Corneal Healing in Patients With Acute Corneal Abrasion

“inabililty to recruit at required rate”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Queen's University

Sponsor type

University, hospital or other

Conditions

Corneal Abrasion

Interventions

Tetracaine 0.5% ophthalmic drops; Normal Saline placebo drops

Participants

0

Trials that died the same way

• Return to Work and Living Healthy After Head and Neck Cancer
  “insufficient recruitment rate” (78% match in meaning)
• Intraocular Pressure (IOP) Patterns in Fast Versus Slow Visual Field (VF) Progression Patients
  “Low recruitment rate” (73% match in meaning)
• Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin
  “Failure to Recruit in a Timely manner” (71% match in meaning)
• Influence of an Inverse Pressure Ramp in Long-term Non-invasive Ventilation on Dyspnea in the Morning After Therapy
  “Insufficient recruitment in a timely manner” (70% match in meaning)
• Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia
  “difficulty of recruitement” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.